-
Mashup Score: 0Hearing loss tech developer Envoy goes public in SPAC deal - 7 month(s) ago
Anzu Special Acquisition Corp. and Envoy Medical announced last week that they completed a previously announced business combination.
Source: www.massdevice.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Sanuwave to go public in $127.5M SPAC merger - 8 month(s) ago
Wound care company Sanuwave Health announced that it entered into a business combination agreement with SEP Acquisition Corp.
Source: www.massdevice.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@SanuwaveTech to go public in $127.5M #SPAC merger | #IPO #woundcare https://t.co/l36Js4wQQ5
-
-
Mashup Score: 1Liquid Death taps Goldman Sachs for initial public offering: report - 10 month(s) ago
Supplying Demand Inc., the Santa Monica, Calif.–based parent of millennial-targeted beverage brand Liquid Death Inc., is working with Goldman Sachs Group…
Source: MarketWatchCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @TarakRindani: #Millennial-targeted beverage brand #LiquidDeath Inc. taps #GoldmanSachs for #IPO: https://t.co/sy1h5qJEtu
-
-
Mashup Score: 0| BioWorld - 12 month(s) ago
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more
Source: www.bioworld.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Med-tech financings April 2023: #Venturecapital comprises 86% of declining #medtech financings in April | #IPO #VC #funding #medicaldevices https://t.co/ZX6GYyJPtc https://t.co/StW0OQCIu7
-
-
Mashup Score: 0Healthtech Startup Portea Receives SEBI Nod For INR 1,000 Cr IPO - 1 year(s) ago
Healthvista India, the parent company of the healthtech startup Portea Medical, has received approval from SEBI for its IPO.
Source: Inc42 MediaCategories: Healthcare Professionals, Latest HeadlinesTweet-
#India #Healthtech #Startup @Porteamedical Receives SEBI Nod For INR 1,000 Cr #IPO | #homehealth https://t.co/yH5r4h76PB
-
-
Mashup Score: 4Biotech startup Structure pulls off rare IPO, raising $161M - 1 year(s) ago
Structure, which is developing a competitor to marketed diabetes and obesity drugs from Novo Nordisk and Eli Lilly, had one of the strongest Wall Street debuts for a new company since 2021.
Source: BioPharma DiveCategories: Future of Medicine, Latest HeadlinesTweet-
Biotech startup Structure pulls off rare IPO, raising $161M https://t.co/IibIfzWDAY #biotech #digitalhealth #IPO
-
-
Mashup Score: 0
“India may see over 100 matured, large-scale profitable/path-to-profitability start-ups in the next five years. With about 20 of them already being listed, about 80 start-ups have the potential to look at an IPO journey,” Redseer said in the report.
Source: The Economic TimesCategories: Healthcare Professionals, Latest HeadlinesTweet-
80 #startups in #India have potential to go for #IPO in next 5 years: report https://t.co/MeinqGCJxM
-
-
Mashup Score: 1Bloomberg - Are you a robot? - 2 year(s) ago
Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy. Need Help? For inquiries related to this message please contact our support team and provide the reference ID below. Block…
Source: www.bloomberg.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@Intel’s Self-Driving Technology @Mobileye Unit Files for #IPO - Bloomberg https://t.co/Ub2XdnAHxZ
-
-
Mashup Score: 0
Mumbai-based Blue Jet Healthcare, is a specialty pharmaceutical and healthcare ingredient and intermediate company
Source: www.business-standard.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
#India specialty pharmaceutical and healthcare ingredient and intermediate company Blue Jet Healthcare files draft papers with Sebi for Rs 2,100-cr #IPO https://t.co/zh7lW9W0Gd
-
-
Mashup Score: 0Akili raises $163M in ‘blank-check’ merger, plans to commercialize digital treatment for ADHD - 2 year(s) ago
Akili’s share price fell as much as 55 percent on the Nasdaq by mid-morning Monday, its first day of trading after merging with a special purpose acquisition company.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@AkiliLabs raises $163M in ‘blank-check’ merger, plans to commercialize #digitaltherapeutics treatment for #ADHD | #SPAC #IPO https://t.co/hLgogt0TUO
-
#Hearingloss tech developer @EnvoyMedical goes public in #SPAC deal | #medicaldevices #IPO #hearing #hearinghealth https://t.co/olbXpOvzjL